These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 35518295)

  • 1. Dual or multiple drug loaded nanoparticles to target breast cancer stem cells.
    Gao Y; Tang M; Leung E; Svirskis D; Shelling A; Wu Z
    RSC Adv; 2020 May; 10(32):19089-19105. PubMed ID: 35518295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting.
    Lv L; Shi Y; Wu J; Li G
    Int J Nanomedicine; 2021; 16():1487-1508. PubMed ID: 33654398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells.
    He L; Gu J; Lim LY; Yuan ZX; Mo J
    Front Pharmacol; 2016; 7():313. PubMed ID: 27679576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.
    Tong M; Deng Z; Yang M; Xu C; Zhang X; Zhang Q; Liao Y; Deng X; Lv D; Zhang X; Zhang Y; Li P; Song L; Wang B; Al-Dherasi A; Li Z; Liu Q
    Cancer Commun (Lond); 2018 Sep; 38(1):56. PubMed ID: 30231942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bright Horizon of Intelligent Targeted-cancer Therapy: Nanoparticles Against Breast Cancer Stem Cells.
    Vaez A; Abbasi M; Shabani L; Azizipour E; Shafiee M; Zare MA; Rahbar O; Azari A; Amani AM; Golchin A
    Curr Stem Cell Res Ther; 2023; 18(6):787-799. PubMed ID: 36200213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance.
    Saha T; Lukong KE
    Front Oncol; 2022; 12():856974. PubMed ID: 35392236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges.
    Lin X; Wang Y; Fang K; Guo Z; Lin N; Li L
    Stem Cell Res Ther; 2023 Dec; 14(1):356. PubMed ID: 38072976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
    Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
    Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
    Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
    Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells.
    Gao Y; Shelling AN; Nolan E; Porter D; Leung E; Wu Z
    J Liposome Res; 2024 Sep; 34(3):489-506. PubMed ID: 38269490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications.
    Wang L; Jin Z; Master RP; Maharjan CK; Carelock ME; Reccoppa TBA; Kim MC; Kolb R; Zhang W
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Targeting of Differentiated Breast Cancer Cells and Breast Cancer Stem Cells by Combination of Docetaxel- and Sulforaphane-Loaded Self-Assembled Poly(D, L-lactide-co-glycolide)/Hyaluronic Acid Block Copolymer-Based Nanoparticles.
    Huang J; Tao C; Yu Y; Yu F; Zhang H; Gao J; Wang D; Chen Y; Gao J; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Zou H; Xu H; Lu Y; Zhong Y
    J Biomed Nanotechnol; 2016 Jul; 12(7):1463-77. PubMed ID: 29337484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity.
    Zhang R; Tu J; Liu S
    Semin Cancer Biol; 2022 Jul; 82():11-25. PubMed ID: 33737107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid nanoparticles coated with hyaluronic acid lipoid for targeted co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
    Yang Z; Sun N; Cheng R; Zhao C; Liu J; Tian Z
    J Mater Chem B; 2017 Sep; 5(33):6762-6775. PubMed ID: 32264326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.
    Paholak HJ; Stevers NO; Chen H; Burnett JP; He M; Korkaya H; McDermott SP; Deol Y; Clouthier SG; Luther T; Li Q; Wicha MS; Sun D
    Biomaterials; 2016 Oct; 104():145-57. PubMed ID: 27450902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Breast Cancer Stem Cells Traits and Drug Resistance.
    Zheng Q; Zhang M; Zhou F; Zhang L; Meng X
    Front Pharmacol; 2020; 11():599965. PubMed ID: 33584277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers to Target Heterogeneous Breast Cancer Stem Cells.
    Hwang-Verslues WW; Lee WH; Lee EY
    J Mol Biomark Diagn; 2012; Suppl 8():6. PubMed ID: 24977105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells.
    Basu SM; Yadava SK; Singh R; Giri J
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111775. PubMed ID: 33940518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy.
    Scioli MG; Storti G; D'Amico F; Gentile P; Fabbri G; Cervelli V; Orlandi A
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
    Chiotaki R; Polioudaki H; Theodoropoulos PA
    Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.